Recombinant Human DR6/TNFRSF21 Fc Chimera Protein, CF
Catalog # 144-DR | R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Accession #
Source
Structure / Form
Conjugate
Applications
Product Specifications
Source
Human DR6 (Gln42 - Leu350) Accession # O75509 |
DIEGRMD | Human IgG1 (Pro100 - Lys330) |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
When recombinant human APP770 is coated at 2 μg/mL (100 μL/well), the concentration of Recombinant Human DR6/TNFRSF21 that produces 50% of the optimal binding response is found to be approximately 20‑100 ng/mL.
Formulation, Preparation and Storage
144-DR
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: DR6/TNFRSF21
Death Receptor 6 (DR6), also known as TNFRSF21 and CD358, is a type I transmembrane protein in the TNF receptor superfamily (1). Human DR6 consists of a 308 amino acid (aa) extracellular domain (ECD) with four cysteine‑rich motifs, a 21 aa transmembrane segment, and a 285 aa palmitylated cytoplasmic region that contains one death domain (2, 3). Within the ECD, human and mouse DR6 share 82% aa sequence identity. DR6 is expressed as an approximately 110 kDa molecule that carries extensive N‑linked and O‑linked glycosylation in its extracellular region (3, 4). Among hematopoietic cells, DR6 is expressed on monocytes, resting CD4+ T cells, and pro‑, pre‑, and naïve B cells (5 ‑ 7). DR6 knockout mice exhibit a Th2‑biased immune response characterized by exaggerated Th2 and B cell responsiveness in combination with reduced Th1 cell responsiveness and inflammatory leukocyte infiltration (6 ‑ 9). DR6 knockout mice are resistant to induced airway inflammation and experimental autoimmune encephalitis but more susceptible to severe graft versus host disease (9 ‑ 11). DR6 is also expressed on developing neurons where it can bind a shed 35 kDa N‑terminal fragment of APP or a fragment of APLP2 (12, 13). This APP fragment is generated following deprivation of neurotrophic factors, and its binding to DR6 triggers DR6‑mediated axonal pruning (12). DR6 is constitutively expressed on some prostate cancer cells and can be induced by TNF‑ alpha on others (3, 4).
References
- Benschop, R. et al. (2009) Adv. Exp. Med. Biol. 647:186.
- Pan, G. et al. (1998) FEBS Lett. 431:351.
- Klima, M. et al. (2009) Biochim. Biophys. Acta 1793:1579.
- Kasof, G.M. et al. (2001) Oncogene 20:7965.
- Matesanz-Isabel, J. et al. (2011) Immunol. Lett. 134:104.
- Schmidt, C.S. et al. (2003) J. Exp. Med. 197:51.
- Liu, J. et al. (2001) Immunity 15:23.
- Zhao, H. et al. (2001) J. Exp. Med. 194:1441.
- Venkataraman, C. et al. (2006) Immunol. Lett. 106:42.
- Schmidt, C.S. et al. (2005) J. Immunol. 175:2286.
- Liu, J. et al. (2002) J. Immunol. 169:3993.
- Nikolaev, A. et al. (2009) Nature 457:981.
- Kuester, M. et al. (2011) J. Mol. Biol. 409:189.
Long Name
Alternate Names
Gene Symbol
UniProt
Product Documents for Recombinant Human DR6/TNFRSF21 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human DR6/TNFRSF21 Fc Chimera Protein, CF
For research use only
Citations for Recombinant Human DR6/TNFRSF21 Fc Chimera Protein, CF (2)
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Human DR6/TNFRSF21 Fc Chimera Protein, CF include:
-
Species: Mouse
Sample Types: Whole Cells
Applications: BioassayNakamichi Y et al. (2007-01-01), Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J. Immunol., 2007-0178(1):192-200.
PMID: 17182555 -
Species: Human
Sample Types: Cell Culture Supernates
Applications: Enzyme AssayTam EM et al. (2004-04-26), Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. U.S.A., 2004-0101(18):6917-22.
PMID: 15118097
There are no citations that match your criteria.
Reconstitution Calculator
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.